DrugPatentWatch Database Preview
Physiological Effect: Decreased Fibrinolysis
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Drugs with Physiological Effect: Decreased Fibrinolysis
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akorn | TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 206594-001 | Sep 28, 2017 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Caplin | TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 212360-001 | Jul 17, 2019 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Akorn | TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 202373-001 | Nov 17, 2011 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Amneal Pharms Co | TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 208840-001 | Feb 28, 2017 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Exela Pharma Scs Llc | TRANEXAMIC ACID | tranexamic acid | SOLUTION;INTRAVENOUS | 212020-001 | Apr 15, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
